These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 83307)

  • 1. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
    Rogers MJ; Law LW
    Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.
    Henriksen O; Law LW; Appella E
    J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.
    Drapkin MS; Appella E; Law LW
    J Natl Cancer Inst; 1974 Jan; 52(1):259-64. PubMed ID: 4129833
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic and biochemical properties of detergent-solubilized tumor-specific transplantation antigen from a simian virus 40-induced neoplasm: brief communication.
    Natori T; Law LW; Appella E
    J Natl Cancer Inst; 1977 Oct; 59(4):1331-3. PubMed ID: 198560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
    Law LW; Takemoto KK; Rogers MJ; Ting RC
    J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
    Natori T; Law LW; Appella E
    Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells.
    Rogers MJ; Law LW; Appella E
    J Natl Cancer Inst; 1977 Oct; 59(4):1291-5. PubMed ID: 198559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 9. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VIII. Retention of SV40 TrAg sites on purified SV40 large T antigen following denaturation with sodium dodecyl sulfate.
    Flyer DC; Tevethia SS
    Virology; 1982 Feb; 117(1):267-70. PubMed ID: 6175086
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein).
    Tevethia SS; Flyer DC; Tjian R
    Virology; 1980 Nov; 107(1):13-23. PubMed ID: 6255675
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of the purification of tumor antigens: progress and problems.
    Law LW
    Arch Geschwulstforsch; 1981; 51(4):294-301. PubMed ID: 6274269
    [No Abstract]   [Full Text] [Related]  

  • 13. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
    Blasecki JW; Tevethia SS
    Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and biochemical properties of soluble tumor-specific transplantation antigen of a simian virus 40-induced neoplasm.
    Appella E; Law LW; Henriksen O
    Cancer Res; 1976 Sep; 36(9 PT 2):3539-44. PubMed ID: 184951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour rejection properties of solubilised TSTA from an SV40-induced neoplasm.
    Law LL; Henriksen O; Appella E
    Nature; 1975 Sep; 257(5523):234-5. PubMed ID: 169475
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative behavior of simian virus 40 T-antigen and of tumor-specific surface and transplantation antigens during partial purification.
    Luborsky SW; Chang C; Pancake SJ; Mora PT
    Cancer Res; 1978 Aug; 38(8):2367-71. PubMed ID: 78758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.
    Glaser M
    Cell Immunol; 1979 Dec; 48(2):339-45. PubMed ID: 228870
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of SV40-related transplantation immunity in mice by BK virus-transformed cells.
    Kato K; Iwamura Y; Kurimura T
    Jpn J Med Sci Biol; 1979 Oct; 32(5):311-4. PubMed ID: 94612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.